These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 582732)

  • 1. Studies on the effect of cyclophosphamide on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Bhide S; Habs M; Reinhold H; Schmähl D
    Arzneimittelforschung; 1979; 29(3):477-9. PubMed ID: 582732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Bhide S; Habs M; Reinbold H; Schmähl D
    J Cancer Res Clin Oncol; 1979 May; 94(1):63-7. PubMed ID: 468900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Habs M; Reinbold H; Eisenbrand G; Bhide S; Goga-Ionescu S; Schmähl D
    J Cancer Res Clin Oncol; 1981; 101(3):285-302. PubMed ID: 7309781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of thioctic acid (alpha-limpoic acid) on the chemotherapeutic efficacy of cyclophosphamide and vincristine sulfate].
    Berger M; Habs M; Schmähl D
    Arzneimittelforschung; 1983; 33(9):1286-8. PubMed ID: 6416261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth characteristics and therapeutic response of transplantable colon tumors in animals.
    Karaivanova MH; Urumov IJ; Boeva MN
    Neoplasma; 1980; 27(3):253-9. PubMed ID: 7453845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments.
    Warenius HM; Freedman LS; Bleehen NM
    Br J Cancer Suppl; 1980 Apr; 4():128-32. PubMed ID: 6932916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies on the effectiveness of various cytostatics and radiation therapy of experimental tumors in a sample experiment with special regard to telegammatherapy with cobalt60. Survival experiments and cures after the administration of cyclophosphamide ester, triethyleneiminebenzoquinone and radiation separately and in various combinations with Yoshida sarcoma, carcinoma Walker and Jensen sarcoma in albino rats].
    Schneider R
    Strahlentherapie Sonderb; 1965; 61():367-72. PubMed ID: 5827135
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of moderate local hyperthermia in combination with chemotherapy with cyclophosphamide or N-nitroso- 1,3-bis(2-chloroethyl)urea(BCNU) on Yoshida sarcoma implanted in the descending colon of rats. 1. Repeated hyperthermia within 8 days and combination of chemotherapy followed by hyperthermia 24 h later].
    Lorenz M; Habs M; Schmähl D
    Langenbecks Arch Chir; 1983; 359(3):205-13. PubMed ID: 6876999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.
    Shirasaka T; Nakano K; Takechi T; Satake H; Uchida J; Fujioka A; Saito H; Okabe H; Oyama K; Takeda S; Unemi N; Fukushima M
    Cancer Res; 1996 Jun; 56(11):2602-6. PubMed ID: 8653704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood lymphocyte nucleoli of rats with Yoshida ascitic sarcoma and the effect of cyclophosphamide.
    Matĕjková E
    Folia Biol (Praha); 1975; 21(5):349-53. PubMed ID: 1201807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inosine pranobex-BAN increases the resistance to the challenge with cells or cell-free fluid from Yoshida ascites tumor.
    Fimiani V; Cavallaro A; Falliti G; Amato A
    Chemioterapia; 1986 Apr; 5(2):128-33. PubMed ID: 2423256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the electrolyte changes in serum and ascites during cytostatic therapy of transplanted tumors].
    Asbach HW
    Arzneimittelforschung; 1968 Sep; 18(9):1180-2. PubMed ID: 5755934
    [No Abstract]   [Full Text] [Related]  

  • 13. Field bean protease inhibitor preparations, unlike methotrexate, can completely suppress Yoshida sarcoma tumor in rats.
    Banerji AP; Fernandes AO
    Cell Biol Int; 1994 Nov; 18(11):1025-34. PubMed ID: 7894388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.
    Wang X; Fu X; Brown PD; Crimmin MJ; Hoffman RM
    Cancer Res; 1994 Sep; 54(17):4726-8. PubMed ID: 8062271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An experimental postoperative metastasis system using Yoshida sarcoma inoculated subcutaneously into footpad.
    Imai R; Ashizawa T; Nakamura N
    Gan; 1975 Feb; 66(1):69-73. PubMed ID: 1158072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the combined treatment of radiation and carcinostatic agents on Yoshida-sarcoma cells].
    Saito T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1965 Nov; 25(8):908-29. PubMed ID: 5230072
    [No Abstract]   [Full Text] [Related]  

  • 18. Doxorubicin and vincristine with methionine depletion contributed to survival in the Yoshida sarcoma bearing rats.
    Nagahama T; Goseki N; Endo M
    Anticancer Res; 1998; 18(1A):25-31. PubMed ID: 9568051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased lifespan by the sequential treatment with improsulfan and cyclophosphamide in rats bearing Yoshida ascites sarcoma.
    Okumoto T; Imamura H
    Chem Pharm Bull (Tokyo); 1976 Aug; 24(8):1913-6. PubMed ID: 184972
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.